Upgrade to SI Premium - Free Trial

JPMorgan Resumes Alkermes (ALKS) at Neutral

July 13, 2026 3:13 AM
JPMorgan analyst Jessica Fye resumes coverage on Alkermes (NASDAQ: ALKS) with a Neutral rating and a price target of $60.00.The ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments New Coverage